Results on the interactome: around 30 approved drugs may show activity against coronavirus

Several media have published an interview with Patrick Aloy, head of the Structural Bioinformatics and Network Biology Lab at IRB Barcelona, in which he talks about a study being done by scientists at the University of California. This study analyses the physical interactions of the coronavirus in order to understand how this virus “sequesters” our proteins to ensure its survival. This research aims to find drugs that can act against these proteins. In this regard, the researchers at the University of California have found 70 compounds, including around 30 drugs authorized by the US Food and Drug Agency(FDA).

Aloy explains that the strategy to look for pharmacological targets among the human proteins with which the virus interacts is pertinent since, among other factors, the virus has very few of its own proteins. However, he goes on to say that there is still a long way to go before a cure can be found.


Link to: Agencia SINC

Link to: Voz Populi

Link to: iLeon

Link to: Herencia genética y